Aesculap: From Products to Process
Like its parent company, B. Braun, Aesculap has built a business around a broad-based offering of products, in this case general and specialty surgical instruments and devices and orthopedic implants. Such a strategy enables Aesculap to leverage everything from product development to sales and marketing. But now, as Aesculap seeks to extend such leveraging to collaborations with its parent company, the company walks a fine line between exploiting natural synergies without sacrificing the focus that made it successful in the first place.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Coronavirus Notebook: EMA Issues Guidance On Development Of Variant Vaccines, EU Leaders Urge Production Ramp-Up
A batch of AstraZeneca/Oxford University coronavirus vaccines has arrived in Ghana, the first country in the world to receive vaccines via the COVAX Facility.
Scanwell Health, a leader in smartphone-enabled home diagnostics tests, has announced a partnership with Beckton Dickson.